Stem Cell Therapy for ALS (Motor Neurone Disease)

Stem cell therapy for amyotrophic lateral sclerosis (ALS, also called motor neurone disease) involves giving mesenchymal or neural cells into the spinal fluid, a vein or the spinal cord, aiming to release protective factors around dying motor neurones and to calm inflammation. The cells are not expected to become new motor neurones.

It remains experimental. Controlled trials so far, including a large phase 3 study of modified mesenchymal cells, did not meet their main goals of slowing the disease, although research continues. It does not stop or reverse ALS, and it should never replace the care that is proven to help.

What Stem Cell Therapy for ALS (Motor Neurone Disease) involves

In the most common protocol, bone marrow is taken from your pelvic bone under local anaesthesia, and mesenchymal stromal cells are isolated and multiplied in a licensed laboratory over 3 to 4 weeks; some programmes use donor umbilical cord cells instead. Each dose is delivered by lumbar puncture into the spinal fluid, sometimes with additional injections into muscle or vein, and repeated every 1 to 3 months for several cycles. Trials measure breathing capacity, the ALS Functional Rating Scale and muscle strength before and after. Direct surgical injection into the spinal cord has been tested only in small academic studies under general anaesthesia.

Who is a good candidate for Stem Cell Therapy for ALS (Motor Neurone Disease)?

The appropriate setting is a registered, ethics-approved clinical trial, ideally one that does not charge participants.

• People with confirmed ALS who meet the criteria of a registered trial
• Those with breathing capacity still adequate for safe procedures and travel
• People who continue riluzole, multidisciplinary care and respiratory support alongside
• Families who understand the evidence and accept that benefit is unlikely

Es ist normalerweise nicht die richtige Wahl, wenn:

• Anyone told that the treatment will halt or cure ALS
• People with advanced breathing weakness, for whom travel and lying flat for lumbar puncture are risky
• Those who would need to sell assets or crowdfund large sums for an unproven therapy
• People with active infection, cancer or on anticoagulants that cannot be paused
• Anyone whose diagnosis has not been confirmed by a neuromuscular specialist

Technikoptionen

• Intrathecal autologous mesenchymal cells: The most tested approach. Safe in trials; a possible short-term slowing in small studies has not been confirmed in larger ones.
• Mesenchymal cells induced to secrete neurotrophic factors: Reached phase 3; the trial missed its primary endpoint, with debated signals in less advanced patients.
• Intraspinal neural stem cell transplantation: Surgically demanding and limited to early-phase research.
• Care with proven benefit: Riluzole, edaravone where available, tofersen for SOD1 gene ALS, non-invasive ventilation, feeding tube support and specialist multidisciplinary clinics.

Was passiert während Ihrer Behandlung

Marrow harvest takes about 30 minutes with local anaesthesia and sedation. Each lumbar puncture takes 15 to 30 minutes, followed by a few hours of lying flat, which may be difficult if your breathing is weak when flat. Headache, back pain and low-grade fever for 1 to 2 days are common.

Vorbereitung auf Ihre Reise

Protocols usually require a first visit for harvest, then 2 to 6 dosing visits a month or more apart. Repeated long-haul travel is tiring and becomes harder as ALS progresses. Ask for trial registration, the Ministry of Health approval that Türkiye requires for individual cell therapy, the laboratory licence and published outcomes. Discuss the plan with your own neurologist before committing.

• Informieren Sie den Arzt über Medikamente, Allergien, Schwangerschaft oder Stillen und eine Vorgeschichte von Fieberbläschen, Keloidnarben oder Autoimmunerkrankungen
• Vermeiden Sie Alkohol, Aspirin und entzündungshemmende Schmerzmittel für ein paar Tage im Voraus, wenn Ihr eigener Arzt zustimmt, um Blutergüsse zu reduzieren
• Kommen Sie ohne Make-up auf dem Behandlungsbereich an und vermeiden Sie zwei Wochen vorher Sonnenliegen und starke Sonne

Genesung und Ergebnisse

You can normally return to usual activities within 1 to 2 days of an injection. There is no expected point at which strength returns. Because ALS progresses at variable rates, only comparison of your measured rate of decline before and after treatment, by an independent clinician, can indicate whether anything changed.

• Zurück zur alltäglichen Aktivität: 1 bis 2 Tage
• When results show: No reliable improvement has been demonstrated
• How long they last: Unknown

Sicherheit, Risiken und Revisionspolitik

Procedure risks are modest in regulated trials; the greater dangers are unregulated products, exhaustion from travel and false hope.

• Post-lumbar-puncture headache and back pain
• Infection including meningitis if cell preparation is substandard
• Breathing difficulty during sedation or when lying flat
• Blood clots from long flights and immobility
• Inflammatory reactions in the spinal fluid
• Financial and emotional cost with no slowing of disease, the most likely outcome

Jeder schriftliche Vorschlag wird durch Clinic-Y gibt an, was die Klinik abdeckt, wenn eine Korrektur erforderlich ist. Fragen Sie danach, bevor Sie buchen, nicht danach.

Cost of Stem Cell Therapy for ALS (Motor Neurone Disease) in Türkiye

Clinic-Y does not publish a single price for Stem Cell Therapy for ALS (Motor Neurone Disease), because the honest figure depends on your case. What moves it:

• Cell processing in a licensed laboratory
• Number of dosing cycles
• Hospital care, including respiratory monitoring
• Travel and carer costs over repeated visits
• Whether the programme is a funded trial or a paid service

Senden Sie Ihre Fotos oder Berichte und Sie erhalten geschrieben, All-inclusive Vorschläge von geeigneten Teams, Seite an Seite. Die Überprüfung Ihres Falls ist kostenlos.

Häufig gestellte Fragen